Sign in

CIK 0001787306

  • Large accelerated filer

Arcutis Biotherapeutics, Inc.

Sign in to watch
Ticker
ARQT
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
812974255
Phone
+1 805-418-5006
Business address
3027 TOWNSGATE ROAD, SUITE 300, WESTLAKE VILLAGE, CA, 91361
Former names
Arcutis, Inc.
  1. 4 Planned sale Watanabe Todd sold 4,375 shares at $26.12 ($114,261)
  2. 4 Grant or award Director acquired 4,315 shares (grant or award)
  3. 3 Insider Initial Statement of Ownership
  4. 4 Planned sale Director sold 4,730 shares at $26.91 ($127,284)
  5. 4 Planned sale Director sold 4,946 shares at $24.38 ($120,587)
  6. 4 Planned sale Director sold 4,731 shares at an average $24.58 ($116,281)
  7. 4/A Insider Changes in Ownership
  8. 4 Grant or award Director acquired 5,778 shares (grant or award)
  9. 4 Grant or award Director acquired 5,778 shares (grant or award)
  10. 4 Grant or award Director acquired 5,778 shares (grant or award)
  11. 4 Grant or award Director acquired 5,778 shares (grant or award)
  12. 4 Grant or award Director acquired 5,778 shares (grant or award)
  13. 4 Grant or award Director acquired 5,778 shares (grant or award)
  14. 4 Grant or award Director acquired 5,778 shares (grant or award)
  15. 4 Grant or award Director acquired 5,778 shares (grant or award)
  16. 4 Planned sale SVP Chief Financial Officer sold 435 shares at $21.05 ($9,157)
  17. 4 Planned sale Burnett Patrick sold 222 shares at $21.05 ($4,673)
  18. 4 Planned sale Matsuda Masaru sold 8,256 shares at an average $23.31 ($192,415)
  19. 4 Planned sale Burnett Patrick sold 684 shares at $23.61 ($16,150)
  20. 4 Planned sale SVP Chief Financial Officer sold 1,341 shares at $23.61 ($31,662)

Page 2 of 23 · 452 filings